Showing results (321-330 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|August 16, 2008
Association of the catechol-O-methyltransferase polymorphism with methylphenidate response in a classroom setting in children with attention-deficit hyperactivity disorderKeun-Ah Cheon, Jin-Yong Jun, Dae-Yeon ChoInternational Clinical Psychopharmacology|August 16, 2008
Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience ScaleJonathan Davidson, David S Baldwin, Dan J Stein, et al.International Clinical Psychopharmacology|December 11, 2013
Socioeconomic factors influencing antipsychotic prescription for schizophrenia inpatients in China: a cross-sectional studyQiuji Xue, Xianjun Xiong, Yi Feng, et al.International Clinical Psychopharmacology|November 13, 2013
The discrepancy between patients and informants on clinician-rated measures in major depressive disorder: implications for clinical trials and clinical practiceEric D Peselow, Reneh Karamians, Marie Lord, et al.International Clinical Psychopharmacology|October 12, 2013
Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparisonDong-Jing Fu, Cynthia A Bossie, Jennifer K Sliwa, et al.International Clinical Psychopharmacology|April 15, 2010
Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose-response studySrihari Gopal, David W Hough, Haiyan Xu, et al.International Clinical Psychopharmacology|June 1, 2010
Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trialSiegfried Kasper, Markus Gastpar, Walter E Müller, et al.International Clinical Psychopharmacology|July 25, 2009
Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary studyEnrico Pessina, Umberto Albert, Filippo Bogetto, et al.International Clinical Psychopharmacology|January 1, 1991
Combination of fluoxetine with pemoline in the treatment of major depressive disorderA Metz, R I ShaderPageof 212